GGrantIndex
← Search

Healthy and At-Risk Populations

$142,225P30FY2013CANIH

University Of California Los Angeles, Los Angeles CA

Investigators

Linked publications, trials & patents

Trial NCT07339085Trial NCT07276438Trial NCT07242365Trial NCT06650163Trial NCT06568016Trial NCT06113016Trial NCT05595499Trial NCT04205838Trial NCT04201873Trial NCT04185311Trial NCT04119024Trial NCT04106362Trial NCT04069923Trial NCT04069910Trial NCT04050215Trial NCT04007029Trial NCT03996850Trial NCT03970252Trial NCT03953157Trial NCT03904251Trial NCT03902951Trial NCT03892720Trial NCT03830918Trial NCT03825796Trial NCT03745690Trial NCT03732950Trial NCT03732352Trial NCT03672773Trial NCT03623854Trial NCT03618134Trial NCT03603223Trial NCT03601455Trial NCT03596710Trial NCT03582774Trial NCT03582475Trial NCT03541850Trial NCT03515577Trial NCT03506802Trial NCT03425461Trial NCT03411070Trial NCT03368547Trial NCT03319342Trial NCT03240861Trial NCT03202472Trial NCT03128619Trial NCT03025139Trial NCT03014804Trial NCT02940262Trial NCT02928510Trial NCT02925351Trial NCT02919332Trial NCT02902757Trial NCT02888301Trial NCT02881242Trial NCT02880020Trial NCT02879994Trial NCT02830165Trial NCT02816879Trial NCT02775292Trial NCT02756130Trial NCT02701153Trial NCT02688348Trial NCT02683200Trial NCT02672033Trial NCT02597894Trial NCT02575027Trial NCT02451865Trial NCT02336763Trial NCT02310594Trial NCT02296229Trial NCT02280161Trial NCT02263898Trial NCT02176902Trial NCT02070406Trial NCT02049593Trial NCT02048020Trial NCT02015559Trial NCT01912820Trial NCT01013285Trial NCT01005472Trial NCT00999557Trial NCT00998010Trial NCT00985192Trial NCT00955591Trial NCT00882765Trial NCT00880542Trial NCT00769470Trial NCT00706615Trial NCT00685516Trial NCT00616642Trial NCT00612066Trial NCT00601289Trial NCT00601094Trial NCT00521209Trial NCT00509431Trial NCT00471887Trial NCT00450567Trial NCT00444223Trial NCT00352001Trial NCT00349167

Abstract

The Healthy and At-Risk Populations Program currently has 26 members, 12 of whom are new to the cancer center. The new members include a number of senior and junior recruits to UCLA, as well as previously unaffiliated UCLA faculty members. A new senior level recruit is Lenore Arab, Ph.D., whose focus is on nutrition and cancer. The JCCC provided critical support for Dr. Arab's research. In addition, we were fortunate that the School of Nursing recently recruited Felicia Hodge, Dr.PH, who is also Director, Center for American Indian/Indigenous Research and Education (CAIRE) on the UCLA campus. Dr. Hodge has a long history of tobacco control and cancer screening research in native American populations and has been an excellent addition to HARP. Also in the past funding cycle, Robert Kaplan, Ph.D., was recruited to be the Chair of Health Services in the School of Public Health, and he has joined HARP. Dr. Kaplan is an internationally renowned scholar in the areas of health services and health psychology and conducts research in broad content areas including tobacco control, cancer screening, quality of life, and quality of care. Other internal senior level faculty who have been attracted to join HARP during the past funding cycle include Lillian Gelberg, M.D., Family Medicine and Leeka Kheifets, Ph.D., Epidemiology. Junior faculty recruited to UCLA during the past cycle who have newly joined the cancer center include Michael Ong, M.D., Ph.D., General Internal Medicine-Health Services and Dominic Frosch, Ph.D., General Internal Medicine-Health Services Research. The Program is extremely dynamic, and is viewed as a welcoming and supportive environment for collaborative research. Our members have national and international reputations, and we have in our program three members of the Institute of Medicine. The total number of publications in the last cycle was 425 out of which 18% were inter-programmatic and 18% were intra-programmatic indicating a high level of collaborative research in the program. Fourteen percent of the publications could be characterized as high impact. During the current funding year, peerreviewed funding totaled $11.4 million in total costs, including $5.3 million from the National Cancer Institute. As with other Program Areas, JCCC fosters a number of interactive activities and many of the Shared Resources that support investigators in the HARP Program Area. During the current grant cycle, funds from the JCCC in the form of CCSG Developmental Funds, institutional support and philanthropic gifts to the HARP Program Area total $348,500. These funds supported Seed Grants, the annual Helene Brown award and trainees. Four of the Program Area Members were the recipients of JCCC support.

View original record on NIH RePORTER →